Navigation Links
Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
Date:7/29/2011

ersion from NEUPOGEN to Neulasta.

Enbrel® (etanercept) sales increased 9 percent to $956 million in the second quarter of 2011 versus $877 million in the second quarter of 2010, driven primarily by increases in the average net sales price and unit demand.  This sales increase reflects segment growth, offset partially by share declines. ENBREL remains the leader in both the rheumatology and dermatology segments.

Sales of Sensipar® / Mimpara® (cinacalcet) increased 16 percent to $199 million in the second quarter of 2011 versus $172 million in the second quarter of 2010.  Sales of Vectibix® (panitumumab) increased 13 percent to $81 million in the second quarter of 2011 versus $72 million in the second quarter of 2010.  Sales of Nplate® (romiplostim) increased 36 percent to $75 million in the second quarter of 2011 versus $55 million in the second quarter of 2010. These increases were driven by increases in global demand.

Sales of Prolia® (denosumab) in the second quarter of 2011 were $44 million, reflecting continued adoption by physicians and expanded access from payers in the U.S. and internationally.

U.S. sales of XGEVA® (denosumab) were $73 million in the second full quarter following launch.  Sales were driven by increased segment share as well as overall segment growth.

Operating Expense Analysis on an Adjusted Basis:Cost of Sales decreased to 14.6 percent of product sales in the second quarter of 2011 versus 15.2 percent of product sales in the second quarter of 2010.  This decrease was driven primarily by lower bulk material cost, due to higher utilization, offset partially by the Puerto Rico excise tax.  Excluding the $45 million impact of the excise tax, cost of sales would have been 13.5 percent of product sales for the quarter.

Research and Development (R&D) expenses increased 26 percent to $808 million in the second quarter of 2011
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
3. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2008 Genta,Incorporated (Nasdaq: GNTA ) announced ... Company,s lead anticancer,compound will be featured at the ... (AACR). The meeting will be held in San ... of several abstracts, which are,relevant to both the ...
... 4, 2008 VIA,Pharmaceuticals (Nasdaq: VIAP ), ... for the treatment of cardiovascular disease,announced today that ... VIA-2291 Phase 2 clinical trial program recently met ... studies. The DSMB observed a,continued acceptable safety profile ...
Cached Medicine Technology:Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 2Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4
(Date:7/10/2014)... News) -- Teens who are sensitive to light or ... emotional symptoms such as anxiety and depression, a new ... may exacerbate issues teens experience after concussion may help ... decisions about when to return to play and what ... authors Lisa Koehl and Dong Han, of the University ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 (HealthDay ... regularly between outspoken celebrities or loudmouth pundits -- too much ... study suggests. High amounts of Twitter use can lead ... in a long-term relationship, according to findings from an online ... can lead to cheating and breakups, the researchers concluded, although ...
(Date:7/10/2014)... responders felt better prepared to respond to an active ... a new study in the journal Prehospital and ... specifically examine the EMS provider comfort level with respect ... yet been neutralized or working with law enforcement personnel ... High School shooting, the Virginia Tech campus shooting, the ...
(Date:7/10/2014)... PHILADELPHIA Reducing the amount of alcoholic beverages ... health, including a reduced risk of coronary heart ... pressure, according to a new multi-center study published ... the Perelman School of Medicine at the University ... previous studies which suggest that consuming light-to-moderate amounts ...
(Date:7/10/2014)... Department of Health and Human Services (HHS) has announced ... Center Seidman Cancer Center totaling $4.7 million to support ... patients with complex cancer. , Titled "Evidence-Conformant Oncology ... at UH to enhance care for adult cancer patients ... high health care utilization. , "We believe ...
Breaking Medicine News(10 mins):Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:New study shows drinking alcohol provides no heart health benefit 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... 17 (HealthDay News) -- Children with bipolar disorder and ... time looking at the eyes when trying to identify ... researchers say. This new study finding may help ... dysregulation have difficulty determining other people,s emotional expressions, said ...
... 17, 2011 -- Factors such as low hemoglobin levels, increased ... higher risk of silent cerebral infarcts (SCIs), or silent strokes, ... from a large, first-of-its-kind study published online today ... the American Society of Hematology (ASH). Silent strokes ...
... (HealthDay News) -- Most people who join gangs have ... that challenges previous research suggesting gang membership is driven ... an antisocial personality are impulsive, lack self-discipline and self-control, ... this, they may be excluded from groups at school ...
... increasingly common, and a dangerous lack of new infection ... than ever to use existing antibiotics appropriately. This week, ... care providers, and policymakers about when antibiotics can help, ... harm than good, and the tremendous need for new ...
... that keep blood vessels open to treat heart disease ... in the Journal of Interventional Cardiology . A ... Grines, of the Detroit Medical Center Cardiovascular Institute, and ... attack after the recently marketed Ion stent (Boston Scientific, ...
... InDevR, a Boulder-based biotechnology company that develops advanced ... viruses and other microorganisms, announced today the launch ... colorimetric detection system that incorporates core technology licensed ... will enhance laboratories around the world by offering ...
Cached Medicine News:Health News:Bipolar Kids May Focus on Different Facial Features 2Health News:Study identifies 'silent' stroke risk factors for children with sickle cell anemia 2Health News:Preserving lifesaving antibiotics today and for the future 2Health News:Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU 2
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
DMSO-resistant microplate sealing film...
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Aluminum Seal, Reflective, Bulk...
Medicine Products: